Mdma molecule:

Image from PubChem

Mdma Clinical Trials

An Open- Label, Phase 2, Multicenter Feasibility Study if Manualized MDMA-Assisted Psychotherapy with an fMRI sub-study Assessing Changes in Brain Activity in Subjects with Posttraumatic Stress Disorder.

To see complete record on, please visit this link

Id: 2018-001718-13

Organisation Name: MAPS Europe B.V.

Start Date: 2019-07-12

Completion Date: Ongoing

Brief Summary: The overall objective of this study is to use standard clinical measures to explore the safety and effects of open-label manualized MDMA-assisted psychotherapy with a flexible dose of MDMA in participants with severe PTSD, and to serve as an opportunity for supervision of therapy teams selected to conduct Phase 3 MDMA-assisted psychotherapy research.

Country: Netherlands

Total execution time in seconds: 0.11267113685608